A novel gene delivery system using urothelial tissue engineered neo- organs

J. J. Yoo, A. Atala

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Purpose: Presently gene delivery is most effectively achieved by ex vivo gene transfer, which includes removal of the target tissue, in vitro gene delivery to the target cells, possible selection to enhance the proportion of transfected cells and reintroduction of the gene modified cells. Reintroduction of transformed cells in vive has been a challenging task. Based on the feasibility of tissue engineering techniques in which cells seeded on biodegradable polymer scaffolds form tissue when implanted in vivo, we explored the possibility of developing a neo-organ system for in vive gene therapy. Materials and Methods: Normal human urothelial cells were harvested, expanded in vitro and seeded on biodegradable polymer scaffolds. The cell- polymer complex was then transfected with PGL3-luc, pCMV-luc and pCMVβ-gal promoter reporter gene constructs. The transfected cell-polymer scaffolds were then implanted in athymic mice and the engineered tissue was retrieved 0, 1, 3, 5 and 7 days after implantation. Results: The reporter gene assay demonstrated an expression of luciferase activity at days 1, 3, 5 and 7 with the peak at day 5. X-gal and β-galactosidase antibody assays stained positive on the deoxyribonucleic acid treated transfection. Conclusions: Successful gene transfer can be achieved using biodegradable polymer scaffolds as a urothelial cell delivery vehicle. The transfected cell- polymer scaffold forms an organ-like structure with functional expression of the transfected genes. This study demonstrates that urothelial tissue engineered gene transfer is safe and effective.

Original languageEnglish
Pages (from-to)1066-1070
Number of pages5
JournalJournal of Urology
Volume158
Issue number3 SUPPL.
DOIs
StatePublished - Aug 25 1997
Externally publishedYes

Fingerprint

Gene Transfer Techniques
Polymers
Genes
Reporter Genes
Galactosidases
Tissue Scaffolds
Tissue Engineering
Luciferases
Nude Mice
Genetic Therapy
Transfection
Gene Expression

Keywords

  • Bladder
  • Gene therapy
  • Genes
  • Organ culture
  • Transfection

ASJC Scopus subject areas

  • Urology

Cite this

A novel gene delivery system using urothelial tissue engineered neo- organs. / Yoo, J. J.; Atala, A.

In: Journal of Urology, Vol. 158, No. 3 SUPPL., 25.08.1997, p. 1066-1070.

Research output: Contribution to journalArticle

Yoo, J. J. ; Atala, A. / A novel gene delivery system using urothelial tissue engineered neo- organs. In: Journal of Urology. 1997 ; Vol. 158, No. 3 SUPPL. pp. 1066-1070.
@article{a5789e651de548beb9ccb838d7ef9eb3,
title = "A novel gene delivery system using urothelial tissue engineered neo- organs",
abstract = "Purpose: Presently gene delivery is most effectively achieved by ex vivo gene transfer, which includes removal of the target tissue, in vitro gene delivery to the target cells, possible selection to enhance the proportion of transfected cells and reintroduction of the gene modified cells. Reintroduction of transformed cells in vive has been a challenging task. Based on the feasibility of tissue engineering techniques in which cells seeded on biodegradable polymer scaffolds form tissue when implanted in vivo, we explored the possibility of developing a neo-organ system for in vive gene therapy. Materials and Methods: Normal human urothelial cells were harvested, expanded in vitro and seeded on biodegradable polymer scaffolds. The cell- polymer complex was then transfected with PGL3-luc, pCMV-luc and pCMVβ-gal promoter reporter gene constructs. The transfected cell-polymer scaffolds were then implanted in athymic mice and the engineered tissue was retrieved 0, 1, 3, 5 and 7 days after implantation. Results: The reporter gene assay demonstrated an expression of luciferase activity at days 1, 3, 5 and 7 with the peak at day 5. X-gal and β-galactosidase antibody assays stained positive on the deoxyribonucleic acid treated transfection. Conclusions: Successful gene transfer can be achieved using biodegradable polymer scaffolds as a urothelial cell delivery vehicle. The transfected cell- polymer scaffold forms an organ-like structure with functional expression of the transfected genes. This study demonstrates that urothelial tissue engineered gene transfer is safe and effective.",
keywords = "Bladder, Gene therapy, Genes, Organ culture, Transfection",
author = "Yoo, {J. J.} and A. Atala",
year = "1997",
month = "8",
day = "25",
doi = "10.1016/S0022-5347(01)64390-8",
language = "English",
volume = "158",
pages = "1066--1070",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - A novel gene delivery system using urothelial tissue engineered neo- organs

AU - Yoo, J. J.

AU - Atala, A.

PY - 1997/8/25

Y1 - 1997/8/25

N2 - Purpose: Presently gene delivery is most effectively achieved by ex vivo gene transfer, which includes removal of the target tissue, in vitro gene delivery to the target cells, possible selection to enhance the proportion of transfected cells and reintroduction of the gene modified cells. Reintroduction of transformed cells in vive has been a challenging task. Based on the feasibility of tissue engineering techniques in which cells seeded on biodegradable polymer scaffolds form tissue when implanted in vivo, we explored the possibility of developing a neo-organ system for in vive gene therapy. Materials and Methods: Normal human urothelial cells were harvested, expanded in vitro and seeded on biodegradable polymer scaffolds. The cell- polymer complex was then transfected with PGL3-luc, pCMV-luc and pCMVβ-gal promoter reporter gene constructs. The transfected cell-polymer scaffolds were then implanted in athymic mice and the engineered tissue was retrieved 0, 1, 3, 5 and 7 days after implantation. Results: The reporter gene assay demonstrated an expression of luciferase activity at days 1, 3, 5 and 7 with the peak at day 5. X-gal and β-galactosidase antibody assays stained positive on the deoxyribonucleic acid treated transfection. Conclusions: Successful gene transfer can be achieved using biodegradable polymer scaffolds as a urothelial cell delivery vehicle. The transfected cell- polymer scaffold forms an organ-like structure with functional expression of the transfected genes. This study demonstrates that urothelial tissue engineered gene transfer is safe and effective.

AB - Purpose: Presently gene delivery is most effectively achieved by ex vivo gene transfer, which includes removal of the target tissue, in vitro gene delivery to the target cells, possible selection to enhance the proportion of transfected cells and reintroduction of the gene modified cells. Reintroduction of transformed cells in vive has been a challenging task. Based on the feasibility of tissue engineering techniques in which cells seeded on biodegradable polymer scaffolds form tissue when implanted in vivo, we explored the possibility of developing a neo-organ system for in vive gene therapy. Materials and Methods: Normal human urothelial cells were harvested, expanded in vitro and seeded on biodegradable polymer scaffolds. The cell- polymer complex was then transfected with PGL3-luc, pCMV-luc and pCMVβ-gal promoter reporter gene constructs. The transfected cell-polymer scaffolds were then implanted in athymic mice and the engineered tissue was retrieved 0, 1, 3, 5 and 7 days after implantation. Results: The reporter gene assay demonstrated an expression of luciferase activity at days 1, 3, 5 and 7 with the peak at day 5. X-gal and β-galactosidase antibody assays stained positive on the deoxyribonucleic acid treated transfection. Conclusions: Successful gene transfer can be achieved using biodegradable polymer scaffolds as a urothelial cell delivery vehicle. The transfected cell- polymer scaffold forms an organ-like structure with functional expression of the transfected genes. This study demonstrates that urothelial tissue engineered gene transfer is safe and effective.

KW - Bladder

KW - Gene therapy

KW - Genes

KW - Organ culture

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=0030843604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030843604&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)64390-8

DO - 10.1016/S0022-5347(01)64390-8

M3 - Article

C2 - 9258143

AN - SCOPUS:0030843604

VL - 158

SP - 1066

EP - 1070

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3 SUPPL.

ER -